Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for kappa 2) opioid receptor
Most Correlated Studies
- L1000 CMAP - Amelanotic malignant melanoma of skin A375 cells treated with ligand perturbagens
- L1000 CMAP - Lung cancer A549 cells treated with ligand perturbagens
- L1000 CMAP - Prostate carcinoma VCaP cells treated with ligand perturbagens
- L1000 CMAP - Adenocarcinoma of breast MCF7 cells treated with ligand perturbagens
- L1000 CMAP - Colorectal cancer HT29 cells treated with ligand perturbagens
Most Relevant Literature
- Activation of Peripheral Opioid Kappa1 Receptor Prevents Cardiac Reperfusion Injury.
- Kappa2 opioid receptor subtype binding requires the presence of the DOR-1 gene.
- The intrathecally administered kappa-2 opioid agonist GR89696 and interleukin-10 attenuate bone canc…
- Essential structure of opioid κ receptor agonist nalfurafine for binding to the κ receptor 2: synthe…
- Regional mRNA expression of the endogenous opioid and dopaminergic systems in brains of C57BL/6J and…
Most Relevant Clinical Trials
- A Study Of Kappa Opioid Receptor Occupancy Of PF-04455242, Using PET (Positron Emission Tomography)
- Kappa Opioid Receptor Imaging in Depression (KOR Depression)
- Kappa Opioid Receptor Imaging in Anorexia
- FASTMAS (Fast-Fail Trials in Mood and Anxiety Spectrum Disorders) Kappa Opioid Receptor Phase 1 Stud…
- Positron Emission Tomography (PET) Trial to Evaluate Target Occupancy of CVL-354 at Kappa and Mu Opi…
